COMMUNIQUÉS West-GlobeNewswire

Informations relatives au nombre total de droits de vote et d’actions composant le capital
03/04/2024
Informations relatives au nombre total de droits de vote et d’actions composant le capital Nantes, le 3 avril 2024 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement [...]
Le KFSH&RC accueille le Dr Björn Zoëga en tant que nouveau directeur général adjoint
03/04/2024
RIYAD, Arabie saoudite, 03 avr. 2024 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital and Research Centre (KFSH&RC) est fier d’annoncer la nomination du Dr Björn Zoëga au poste de directeur général adjoint, à [...]
ALPHA PRO TECH, LTD. ANNOUNCES $2 MILLION EXPANSION OF SHARE REPURCHASE PROGRAM
03/04/2024
Nogales, Arizona, April 03, 2024 (GLOBE NEWSWIRE) -- Alpha Pro Tech, Ltd. (NYSE American: APT) , a leading manufacturer of products designed to protect people, products and environments, including disposable protective [...]
Clearday to Present at the Emerging Growth Conference on April 4, 2024
03/04/2024
Clearday invites individual and institutional investors, advisors and analysts to attend its real-time, interactive presentation at the Emerging Growth Conference. San Antonio, TX, April 03, 2024 (GLOBE NEWSWIRE) -- [...]
Major shareholder announcement – Swedbank Robur Fonder AB
03/04/2024
ANNOUNCEMENT NO. 259 Major shareholder announcement Major shareholder announcement – Swedbank Robur Fonder AB Pursuant to Section 38 of the Danish Capital Markets Act, it is hereby announced that Swedbank Robur Fonder [...]
Grant of share-based long-term incentive instruments to members of the Board of Management and key employees
03/04/2024
ALK ( ALKB:DC / OMX: ALK B / AKBLF ): According to the Company’s remuneration policy adopted at the Company's Annual General Meeting on 23 March 2023 and in line with the Company’s usual practice, the Board of Directors [...]
PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE ACVSMR SYMPOSIUM IN NAPLES FLORIDA
03/04/2024
MINNEAPOLIS, April 03, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for [...]
TransCode Therapeutics Reports 2023 Results; Provides Business Update
03/04/2024
BOSTON, April 03, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today reported financial results for [...]
ARS Pharmaceuticals Submits Response to FDA Complete Response Letter for neffy® (Epinephrine Nasal Spray)
03/04/2024
Response addresses all additional requests in FDA CRL, including positive data from a repeat dose PK/PD study of neffy under nasal allergen challenge (NAC) conditions, and updated testing that detected no measurable [...]
Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on April 4, 2024
03/04/2024
Webcasted presentation to take place at 3:10pm ET GAITHERSBURG, Md., April 03, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical [...]
Creative Health Care Management Donna Wright Awarded the 2024 Marlene Kramer Lifetime Achievement Award
03/04/2024
Bloomington, MN, April 03, 2024 (GLOBE NEWSWIRE) -- Creative Health Care Management (CHCM) is delighted to announce that Donna Wright has been chosen as the recipient of the prestigious 2024 Marlene Kramer Lifetime [...]
DiagnaMed Adds New Launch Site of CERVAI™ Brain Health AI
03/04/2024
TORONTO, April 03, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), an artificial intelligence digital healthcare company, today announced it has added Drexel [...]
XOMA Corporation Announces Closing of Tender Offer
03/04/2024
Kinnate Stockholders to Receive $2.5879 Per Share in Cash Plus Contingent Value Right EMERYVILLE, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) (“XOMA” or the “Company”), a biotechnology [...]
InspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conference
03/04/2024
TEL AVIV, Israel and MIAMI, April 03, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced that Marvin [...]
Imidex Hires Wes Bolsen as CEO to Commercialize FDA-Cleared Artificial Intelligence Device for Lung Nodule and Mass Detection, Indicative of Potential Early-Stage Lung Cancer
03/04/2024
Company is evaluating strategic partners and potential acquirers who could potentially treat 50% more lung nodule patients in the U.S. and save billions of dollars annually in healthcare costs DENVER, April 03, 2024 ( [...]
Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement with KARL STORZ SE & Co. KG
03/04/2024
KARL STORZ to provide up to $20 million in bridge financing RESEARCH TRIANGLE PARK, N.C., April 03, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical , Inc. (NYSE American: ASXC) (“Asensus” or the “Company”), a medical device [...]
Surrozen Publishes Study in 'Respiratory Research' Demonstrating the Promise of a Wnt Mimetic Antibody in Treating Pulmonary Fibrosis
03/04/2024
In a preclinical model of pulmonary fibrosis, a Surrozen antibody-based SWAP platform molecule decreased pulmonary inflammation and fibrosis and improved lung function Surrozen Wnt mimetic SWAP molecules also expanded [...]
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within PRC Alliance Pain Relief Center in Ormond Beach, Florida
03/04/2024
PRC Alliance Pain Relief Center operates 8 locations across central Florida Dr. Bakshi reports 100% success performing Epidural Steroid Injection (ESI) procedures during evaluation period ROSELAND, N.J., April 03, 2024 [...]
Lisata Therapeutics to Participate in Upcoming April 2024 Industry and Investor Events
03/04/2024
BASKING RIDGE, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of [...]

Pages